Difference between revisions of "I-123 Biomarker Committee"
Jump to navigation
Jump to search
| Line 19: | Line 19: | ||
*[[Media:QIBA SPECT I-123 BC (11.16.2018).pdf | QIBA SPECT I-123 Biomarker Committee Presentation (11.16.2018)]] ''John Seibyl, MD'' | *[[Media:QIBA SPECT I-123 BC (11.16.2018).pdf | QIBA SPECT I-123 Biomarker Committee Presentation (11.16.2018)]] ''John Seibyl, MD'' | ||
| + | |||
| + | ==QIBA Funded Projects== | ||
| + | |||
| + | ====Round 6==== | ||
Revision as of 16:37, 25 March 2019
- Co-chairs: John Dickson, PhD; John Seibyl, MD
- Secretary: Julie Lisiecki
Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases
Recent Meetings/Call Summaries
Profile Development
Reference Materials
- QIBA SPECT I-123 Biomarker Committee Presentation (11.16.2018) John Seibyl, MD